{"doc_desc":{"title":"Enqu\u00eate sur la douleur et l\u2019inconfort des patients Covid 19","idno":"FRESH-PEF73972-fr","producers":[{"name":"","affiliation":""}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73972-fr","IDno":{"metadata_no":[{"agency":"PEF","code":"73972"},{"agency":"FReSH","code":"FRESH-PEF73972"}]},"title":"Enqu\u00eate sur la douleur et l\u2019inconfort des patients Covid 19","alternate_title":"AlgoCovid"},"study_authorization":{"agency":[{"name":"CNIL"}]},"authoring_entity":[{"name":"Beno\u00eet;LAFON","firstname":"Beno\u00eet","lastname":"LAFON","type":"investigator","extlink":[{"title":"","uri":"","role":"organisation id"}],"email":"lafonb@ch-blois.fr","affiliationName":"","PILabo":"","isContact":true}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"LA DOULEUR ET LE PATIENT DOULOUREUX","extlink":[{"title":"SIREN","uri":"793531658","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":""}]},"distribution_statement":{"contact":[{"name":"Beno\u00eet;LAFON","lastname":"LAFON","firstname":"Beno\u00eet","type":"contact","email":"lafonb@ch-blois.fr","affiliationName":null,"contactPointLabo":"","extlink":[]}]},"study_info":{"keywords":[],"topics":[{"topic":"Infectiologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/fa2ceeab-3b2f-45e9-9243-e5a8005b98de"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D055552"}]},{"topic":"Douleur","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/661232217","title":"CIM-11"}]},{"topic":"COVID-19","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/1730556128","title":"CIM-11"}]}],"purpose":"Cette \u00ab Enqu\u00eate sur la douleur et l\u2019inconfort des patients Covid 19 \u00bb a pour objectif de d\u00e9velopper nos connaissances sur les douleurs aigu\u00ebs durant la maladie CoVid19 ainsi que les douleurs et l\u2019inconfort persistant aux d\u00e9cours de la phase aigu\u00eb de cette maladie Objectifs secondaires : \u0095 Conna\u00eetre la localisation et le type de douleur et l\u2019intensit\u00e9 de ces douleurs, le nombre de syndrome douloureux diff\u00e9rents durant la phase aigu\u00eb et apr\u00e8s la phase aigu\u00eb de la maladie. \u0095 Conna\u00eetre la pr\u00e9valence sp\u00e9cifique de chacun des syndromes douloureux identifi\u00e9s et notamment la pr\u00e9valence des douleurs neuropathiques. \u0095 Conna\u00eetre les composants de l\u2019inconfort r\u00e9siduel. \u0095 Les crit\u00e8res de jugement, pour chaque param\u00e8tre mesur\u00e9, sont les taux de r\u00e9ponses positives aux rubriques existantes correspondantes (colonnes sp\u00e9cifiques de la grille de recueil) ou les taux de r\u00e9ponses positives aux rubriques construites lors de l\u2019analyse (colonnes de calcul ajout\u00e9es, pour r\u00e9pondre \u00e0 des objectifs combinant plusieurs rubriques existantes).","abstract":"","coll_dates":[{"start":"","end":""}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Masculin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"F\u00e9minin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Adolescence (13 \u00e0 18 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000293\"\n            }\n        },\n        {\n            \"value\": \"Adulte (19 \u00e0 24 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adulte (25 \u00e0 44 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Adulte (45 \u00e0 64 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        },\n        {\n            \"value\": \"Personne \u00e2g\u00e9e (65 \u00e0 79 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000368\"\n            }\n        },\n        {\n            \"value\": \"Grand \u00e2ge (80 ans et plus)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000369\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Crit\u00e8res d\u2019\u00e9ligibilit\u00e9 : \u0095 Sujet adulte (18 ans ou plus) de sexe f\u00e9minin ou masculin \u0095 Dossier AppliSamu cod\u00e9 VIN02, VIN03 ou VIN06 entre le 01\\\/03 et 31\\\/05\\\/2020  Crit\u00e8res d\u2019inclusion : \u0095 D\u00e9croch\u00e9 t\u00e9l\u00e9phonique (trois tentatives maximum) \u0095 Accord oral du patient pour un entretien au t\u00e9l\u00e9phone  \u0095 Maladie CoVid19 confirm\u00e9e par l\u2019une des conditions suivantes : -  Codage AppliSamu VIN06 (= CoVid19 av\u00e9r\u00e9) -  Codage VIN02 ou VIN03 (= CoVid19 suspect\u00e9) et patient affirmant avoir \u00e9t\u00e9 diagnostiqu\u00e9 positif (en PCR, scanner ou consultation infectiologie) \",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es rapport\u00e9es par le participant de l'\u00e9tude']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[]},"method":{"data_collection":{"time_method":"","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Autre\"}']","sample_frame":{"frame_unit":{"unit_type":""}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Transcription\",\"vocab\":\"CESSDA\"},\"value\":\"Transcription et saisie d\u2019informations dans un enregistrement structur\u00e9\"}","{\"concept\":{\"vocabURI\":\"Interview\",\"vocab\":\"CESSDA\"},\"value\":\"Entretien avec le participant (dont clinique)\"}"],"research_instrument":"","sources":[],"target_sample_size":"[1000-10000[ individus","response_rate":"1000"},"method_notes":"Etude observationnelle","study_class":"Inconnu","notes":[{"subject":"research type","values":["Etude observationnelle"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"A d\u00e9finir\",\"extLink\":[]}"},"dataset_use":{"restrictions":"","conditions":"","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"fr","originLang":"fr","autoTranslation":false,"status":"imported","creationDate":"24-02-2021","lastUpdatedAuto":null,"lastUpdatedManual":"23-04-2021","isContributorPI":false,"contributorName":"","contributorAffiliation":"","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":[],"otherFundingAgentType":[]},"sponsor":{"sponsorType":["Priv\u00e9 \u00e0 but non lucratif"],"otherSponsorType":[""]},"governance":{"committee":""},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":"","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":false},"geographicalCoverage":{"geoDetail":""},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"","isDataInBiobank":"","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":true,"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}